Presurgical somatostatin receptor ligand treatment does not affect tumor consistency in GH-secreting pituitary macroadenomas

PURPOSE: To evaluate whether presurgical treatment using long-acting somatostatin receptor ligands (SRL) may change pituitary tumor consistency and improve surgical outcome in GH-secreting pituitary macroadenomas. METHODS: Retrospective study of 40 patients with GH-secreting pituitary macroadenomas...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Endocr Connect
Main Authors: Araujo-Castro, Marta, Pian, Héctor, Ruz-Caracuel, Ignacio, Acitores Cancela, Alberto, Pascual-Corrales, Eider, Rodríguez Berrocal, Víctor
Format: Artigo
Jezik:Inglês
Izdano: Bioscientifica Ltd 2020
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7923129/
https://ncbi.nlm.nih.gov/pubmed/33289697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-20-0414
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki